Cubist Systematic Strategies, LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$420,000
+431.6%
46,771
+207.6%
0.03%
+440.0%
Q4 2015$79,000
+690.0%
15,207
+784.1%
0.01%
+400.0%
Q3 2015$10,000
-23.1%
1,720
+22.9%
0.00%0.0%
Q3 2014$13,0001,4000.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2016
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$4,618,0003.71%
GREAT POINT PARTNERS LLC 1,282,527$6,669,0002.80%
Broadfin Capital, LLC 2,412,995$12,548,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 685,000$3,562,0000.52%
GLOBEFLEX CAPITAL L P 209,787$1,091,0000.29%
TFS CAPITAL LLC 477,884$2,485,0000.27%
FT Options LLC 127,400$220,0000.16%
Tourbillon Capital Partners, L.P. 1,264,999$6,578,0000.15%
Birchview Capital, LP 40,000$208,0000.12%
SECOR Capital Advisors, LP 70,111$365,0000.10%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders